Will Lipocine stock go up?

According to Danelfin AI, Lipocine has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (48.58%) is -2.24% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Lipocine stock?

The Lipocine target price is $2.41 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Lipocine stock right now?

Lipocine has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (48.58%) is -2.24% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Lipocine stock is a good buy .

Is Lipocine undervalued right now?

Based on analysts, the average price target downside for Lipocine is 0.00% (1Y). According to Danelfin AI, Lipocine has today an AI Score of 4/10 (Hold Rating).

What was the price range of Lipocine stock over the past 12 months?

The Lipocine stock price range over the past 12 months has been $1.94 - $11.26.

What is going on with Lipocine stock in the last 3 months?

The Lipocine stock performance in the last quarter has been -73.94%.

Does Lipocine offer dividend payments?

No, Lipocine does not currently pay dividends.

What is the current market capitalization of Lipocine?

Lipocine's market cap is $19.7M, as of 2026-07-03 08:00.

Lipocine Inc (LPCN) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

LPCN AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Sentiment+1.93%
How analysts and the market view the stock
Momentum+0.98%
Direction and strength of recent price movements

Profitability-1.51%
Profitability and operating efficiency metrics
Earnings Quality-1.28%
Stability and reliability of reported earnings
Size & Liquidity-1.08%
Company size and trading liquidity
Volatility-0.99%
How much the stock price tends to fluctuate
Valuation-0.29%
How the stock is priced relative to its fundamentals

LPCN probability advantage of beating the market (3M):

-2.24%

AI Score

Hold

Lipocine (LPCN) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of -2.24% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of LPCN (48.58%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
LPCN probability advantage of beating the market (3M)-2.24%
LPCN probability of beating the market (3M)48.58%

LPCN probability advantage of beating the market (3M): -2.24%

The AI-powered overall analysis of Lipocine (LPCN) is based on the 27 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of LPCN:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Technical	Chart Pattern (180d)	figure_86	N/A	-2.62%
Sentiment	Industry (GICS)	Pharmaceuticals	N/A	+2.00%
Technical	Chart Pattern (120d)	figure_9	N/A	+1.80%
Technical	Chart Pattern (252d)	figure_18	N/A	+1.75%
Technical	Chart Pattern (504d)	figure_83	N/A	-1.65%
Fundamental	Gross Margin	100		-1.51%
Technical	Technicals Impact (Long Tail)	-	N/A	+1.35%
Technical	Maximum Volatility	9.49%		-1.31%
Fundamental	Sloan Ratio	0.33		-1.28%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-1.13%
Technical	Upgrade to unlock			-1.08%
Fundamental	Upgrade to unlock			-1.08%
Technical	Upgrade to unlock			+0.96%
Technical	Upgrade to unlock			+0.93%
Technical	Upgrade to unlock			-0.84%

Rest of Alpha Signals: +1.47%

LPCN probability advantage of beating the market (3M)Total:-2.24%
LPCN AI Score

Significant changes Vs previous day

LPCN Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$2.41
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

LPCN Proven Hold Signal & Price Forecast

This is the price chart for LPCN from January 3, 2026 until today. The chart indicates, in yellow, the 0 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

LPCN Average Past Performance & Win Rate

Three months after its 1227 Hold signals since July 2026, LPCN had an average performance of xxxxxxx and a xxxxxx Win rate (positive performance).

1227 Past LPCN Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+9.79%
Average Alpha				-6.20%
Win Rate (% Positive Perf.)				36.08%
% Positive Alpha				31.58%

LPCN Frequently Asked Questions

Will Lipocine stock go up?
According to Danelfin AI, Lipocine has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (48.58%) is -2.24% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Lipocine stock?
Is it a good time to buy, sell, or hold Lipocine stock right now?
Is Lipocine undervalued right now?
What was the price range of Lipocine stock over the past 12 months?
What is going on with Lipocine stock in the last 3 months?
Does Lipocine offer dividend payments?
What is the current market capitalization of Lipocine?

Lipocine Inc Company Profile

Lipocine Inc. represents a critical player in the biopharmaceutical industry, with its strategic emphasis on researching pioneering drug delivery methods for central nervous system (CNS) disorders. Positioned at the vanguard of its product lineup is TLANDO, a state-of-the-art oral testosterone replacement therapy (TRT) that contains testosterone undecanoate.

The company's robust development pipeline features an array of promising candidates, including TLANDO XR—an oral TRT cohort developed for once-daily administration which successfully concluded Phase 2b clinical trials. They also oversee LPCN 1148, a cutting-edge oral prodrug based on bioidentical testosterone purposed for cirrhosis treatment and currently progressing through Phase 2 clinical trials.

Furthermore, Lipocine Inc.'s commitment to revolutionizing neurobiological treatment surfaces in LPCN 1154—an oral neurosteroid being developed as part of Phase 2 studies to tackle postpartum depression, and LPCN 2101—a NAS candidate dedicated to aiding women with epilepsy. Their efforts extend to researching LPCN 2203's potential benefits in alleviating essential tremor conditions.

Additionally, Lipocine Inc. actively pursues innovation in the hepatology space with LPCN 1144—an oral prodrug of bioidentical testosterone designed for managing pre-cirrhotic non-alcoholic steatohepatitis cases having already cleared Phase 2 testing. The portfolio concludes with LPCN 1107—another distinctive oral candidate for harnessing a formulation of 17-alpha-hydroxy progesterone caproate product—currently being evaluated in Phase 3 studies geared towards preventing recurrent preterm birth.

Founded in the year 1997, Lipocine Inc.'s headquarters can be found nestled amidst the picturesque landscapes of Salt Lake City, Utah.

Sector:Health Care
Country:United States
Industry:Pharmaceuticals
Address:675 S Arapeen Dr Ste 202, Salt Lake City
Employees:14
Website:lipocine.com

Pros

Proprietary oral drug delivery technology platform

Addressing unmet medical needs in men's and women's health

Potential for patent-protected market exclusivity

Oral formulation advantage for patient convenience

Pipeline diversification across therapeutic areas

Cons

High regulatory approval hurdles for pharmaceutical products

Intense competition in target therapeutic markets

Substantial capital requirements for drug development

Reliance on successful clinical trial outcomes

Product concentration risk in early-stage pipeline

Company	AI Score	Compare
LXRXLexicon Pharmaceuticals Inc
CTXRCitius Pharmaceuticals Inc
LGNDLigand Pharmaceuticals Inc
LBRXLB Pharmaceuticals Inc
IXHLIncannex Healthcare Inc

Company	AI Score	Compare
LXRXLexicon Pharmaceuticals Inc
CTXRCitius Pharmaceuticals Inc
LGNDLigand Pharmaceuticals Inc
LBRXLB Pharmaceuticals Inc
IXHLIncannex Healthcare Inc

LPCN Stock AI Analysis High Risk

Lipocine Inc

LPCN Stock AI Analysis

Lipocine Inc

LPCN AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

AI Score Explanation

Generating AI Score explanation

AI Score Alpha Factors

Alpha Signals: What Drives the AI Score

LPCN probability advantage of beating the market (3M): -2.24%

LPCN Trading Parameters

LPCN Proven Hold Signal & Price Forecast

LPCN Average Past Performance & Win Rate

LPCN Frequently Asked Questions

Will Lipocine stock go up?

What is the target price for Lipocine stock?

Is it a good time to buy, sell, or hold Lipocine stock right now?

Is Lipocine undervalued right now?

What was the price range of Lipocine stock over the past 12 months?

What is going on with Lipocine stock in the last 3 months?

Does Lipocine offer dividend payments?

What is the current market capitalization of Lipocine?

Lipocine Inc Company Profile

Pros

Cons

Pros

Cons

LPCN Company Profile Summary

LPCN Related Investment Themes

LPCN Related Stocks

LPCN Top 10 Industry Stocks

Pharmaceuticals

LPCN Top 10 Sector Stocks

Health Care

LPCN Stock AI Analysis High Risk

Lipocine Inc

NASDAQ NMS - GLOBAL MARKET

Will Lipocine stock go up?

What is the target price for Lipocine stock?

Is it a good time to buy, sell, or hold Lipocine stock right now?

Is Lipocine undervalued right now?

What was the price range of Lipocine stock over the past 12 months?

What is going on with Lipocine stock in the last 3 months?

Does Lipocine offer dividend payments?

What is the current market capitalization of Lipocine?

NASDAQ NMS - GLOBAL MARKET

LPCN Proven Hold Signal & Price Forecast

Pros

Cons

AI Score Explanation

Generating AI Score explanation